Animal models in the evaluation of antimicrobial agents.
作者信息
Zak O, O'Reilly T
机构信息
Pharmaceutical Research Department, CIBA-GEIGY Limited, Basel, Switzerland.
出版信息
Antimicrob Agents Chemother. 1991 Aug;35(8):1527-31. doi: 10.1128/AAC.35.8.1527.
Abstract
摘要
相似文献
1
Animal models in the evaluation of antimicrobial agents.抗菌药物评价中的动物模型。
Antimicrob Agents Chemother. 1991 Aug;35(8):1527-31. doi: 10.1128/AAC.35.8.1527.
2
The use of rodent models in assessing antimicrobial activity against Mycobacterium leprae.啮齿动物模型在评估抗麻风分枝杆菌抗菌活性中的应用。
Lepr Rev. 1986;57 Suppl 3:137-48. doi: 10.5935/0305-7518.19860106.
3
Pharmacokinetic and pharmacodynamic models of antimicrobial drugs in vitro and in vivo.抗菌药物在体外和体内的药代动力学和药效学模型。
Infection. 1994 Nov-Dec;22(6):377-8. doi: 10.1007/BF01715491.
4
The worm turns for antimicrobial discovery.蠕虫转向抗菌药物发现领域。
Nat Biotechnol. 2006 Sep;24(9):1098-100. doi: 10.1038/nbt0906-1098.
5
Procedures for establishing efficacy of antimicrobial agents for chemotherapeutic caries prevention.确定用于化学防龋的抗菌剂疗效的程序。
J Dent Res. 1994 Mar;73(3):695-703. doi: 10.1177/00220345940730031601.
6
Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi.筛选美国国立癌症研究所-药物研发技术平台（NCI-DTP）文库以鉴定针对伯氏疏螺旋体的新型候选药物。
J Antibiot (Tokyo). 2017 Mar;70(3):308-312. doi: 10.1038/ja.2016.131. Epub 2016 Nov 9.
7
Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models.抗菌药物在动物模型中的药代动力学、药效学与疗效之间的相关性。
Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):479-87. doi: 10.1007/BF01964287.
8
Compound screening: Fresh hunting ground.化合物筛选：新的探索领域。
Nature. 2016 May 12;533(7602):S65-7. doi: 10.1038/533S65a.
9
The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones.
Bioorg Med Chem Lett. 2004 Jun 21;14(12):3069-72. doi: 10.1016/j.bmcl.2004.04.037.
10
In vivo infection models in the pre-clinical pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.在抗菌药物临床前药代动力学/药效学评价中的体内感染模型。
Curr Opin Pharmacol. 2017 Oct;36:94-99. doi: 10.1016/j.coph.2017.09.004. Epub 2017 Sep 29.
引用本文的文献
1
Biofilm formation and dispersal of wound isolates in microtiter plate-based 2-D wound model.基于微孔板的二维伤口模型中伤口分离株的生物膜形成与分散
Heliyon. 2024 Jul 2;10(13):e33872. doi: 10.1016/j.heliyon.2024.e33872. eCollection 2024 Jul 15.
2
Improving the Predictive Value of Preclinical Mouse Models of Pseudomonas aeruginosa Respiratory Infection to Evaluate Antibiotic Efficacy.提高铜绿假单胞菌呼吸道感染临床前小鼠模型预测抗生素疗效的价值。
Methods Mol Biol. 2024;2721:215-231. doi: 10.1007/978-1-0716-3473-8_15.
3
Antimicrobial FiteBac® K21 promotes antimicrobial Potency and wound healing.抗菌产品FiteBac® K21可增强抗菌效力并促进伤口愈合。
Heliyon. 2023 Aug 19;9(8):e19282. doi: 10.1016/j.heliyon.2023.e19282. eCollection 2023 Aug.
4
Study on skin infection model of based on analytic hierarchy process and Delphi method.基于层次分析法和德尔菲法的皮肤感染模型研究
Heliyon. 2023 May 16;9(6):e16327. doi: 10.1016/j.heliyon.2023.e16327. eCollection 2023 Jun.
5
Innovative Strategies to Overcome Antimicrobial Resistance and Tolerance.克服抗菌耐药性和耐受性的创新策略
Microorganisms. 2022 Dec 21;11(1):16. doi: 10.3390/microorganisms11010016.
6
Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.用于评估抗菌药物的小鼠细菌性肺炎模型的变异性
Front Microbiol. 2022 Sep 8;13:988728. doi: 10.3389/fmicb.2022.988728. eCollection 2022.
7
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol.体内研究抗生素联合治疗耐碳青霉烯类革兰氏阴性菌：一项系统评价和荟萃分析方案
BMJ Open Sci. 2020 Jul 21;4(1):e100055. doi: 10.1136/bmjos-2019-100055. eCollection 2020.
8
Anti-microbial Effects In Vitro and In Vivo of Alstonia scholaris.印度萝芙木的体外和体内抗菌作用
Nat Prod Bioprospect. 2021 Feb;11(1):127-135. doi: 10.1007/s13659-020-00294-6. Epub 2021 Jan 3.
9
Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.糖原贮积病的临床前研究：当前动物模型的综合综述。
Int J Mol Sci. 2020 Dec 17;21(24):9621. doi: 10.3390/ijms21249621.
10
Development of biomimetic antimicrobial platelet-like particles comprised of microgel nanogold composites.由微凝胶纳米金复合材料构成的仿生抗菌血小板样颗粒的研制。
Regen Eng Transl Med. 2020;6:299-309. doi: 10.1007/s40883-019-00121-6. Epub 2019 Aug 6.
本文引用的文献
1
A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies.细菌性脑膜炎发病机制的思考：实验与临床研究综述
Yale J Biol Med. 1960 Feb;32(4):280-309.
2
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.种间尺度缩放、异速生长、生理时间与药代动力学的基本框架
J Pharmacokinet Biopharm. 1982 Apr;10(2):201-27. doi: 10.1007/BF01062336.
3
Scope and limitations of experimental chemotherapy.实验性化疗的范围与局限性
Experientia. 1980 Apr 15;36(4):479-83. doi: 10.1007/BF01975159.
4
Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.铜绿假单胞菌体内模型中氨基糖苷类耐药变体的筛选
J Infect Dis. 1982 Nov;146(5):691-7. doi: 10.1093/infdis/146.5.691.
5
Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.根据动物药代动力学参数预测β-内酰胺类抗生素在人体内的处置情况。
J Pharmacokinet Biopharm. 1984 Jun;12(3):241-61. doi: 10.1007/BF01061720.
6
Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis.中心静脉导管相关性心内膜炎：心内膜炎动物实验模型的人类对应情况
Rev Infect Dis. 1984 Nov-Dec;6(6):783-90. doi: 10.1093/clinids/6.6.783.
7
Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison.
Rev Infect Dis. 1984 May-Jun;6(3):357-63. doi: 10.1093/clinids/6.3.357.
8
In vivo evaluation of antibacterial chemotherapeutic substances.抗菌化疗物质的体内评估。
Adv Appl Microbiol. 1971;14:151-83. doi: 10.1016/s0065-2164(08)70543-4.
9
Animal scale-up.动物放大
J Pharmacokinet Biopharm. 1973 Oct;1(5):435-61. doi: 10.1007/BF01059667.
10
Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection.抗生素体外抗菌活性与动物感染模型中的抗菌活性的相关性。
J Antimicrob Chemother. 1985 Jan;15 Suppl A:273-82. doi: 10.1093/jac/15.suppl_a.273.
Zotero 插件